News
Patterson Companies Inc. PDCO, +2.68% said Thursday that is has named Don Zurbay as chief executive officer. Zurbay, who was most recently the dental and animal health company’s chief financial officer, succeeds Mark Walchirk as CEO. Walchirk had resigned from the company, after it was determined that he “violated company policy and demonstrated poor judgment […]
Shares of Relmada Therapeutics Inc. RLMD, -78.23% fell 80.0% in premarket trading on Thursday after the biotech said its experimental treatment for major depressive disorder as a monotherapy did not meet the primary endpoint in a Phase 3 clinical trial. The company said it is still enrolling patients in two other late-stage studies assessing the […]
Bitcoin (BTC) began Oct. 13 with classic fluctuations around $19,000 as markets prepared for crucial macro data. BTC/USD 1-hour candle chart (Bitstamp). Source: TradingView No sign of upside ahead of key U.S. data Data from Cointelegraph Markets Pro and TradingView showed BTC/USD threatening downside at the time of writing with hours to go until the […]
The U.S. Energy Information Administration reported on Thursday that domestic natural-gas supplies rose by 125 billion cubic feet for the week ended Oct. 7. That compared with the average analyst forecast for an increase of 123 billion cubic feet, based on a survey conducted by S&P Global Commodity Insights. Total working gas stocks in storage […]
The financial sector reversed course to trade broadly lower Thursday, along with the broader stock market, after data showed that consumer inflation rose more than expected in September. The SPDR Financial Select Sector ETF XLF, -2.06% sank 1.8% in premarket trading, after being up about 1.3% just before the inflation data was released, as futures […]
Shares of Novavax Inc. NVAX, -6.03% were down 3.4% in premarket trading on Thursday after the company said its combination COVID-19 vaccine and flu shot candidate generated an immune response in a Phase 1/2 clinical trial. Novavax also said that the safety and tolerability of the combination vaccine was consistent with getting a standalone COVID-19 […]